NO20032846L - Makrolider - Google Patents

Makrolider

Info

Publication number: NO20032846L
Authority: NO; Norway
Prior art keywords: macrolides
Prior art date: 2000-12-21

Application number

NO20032846A

Other languages

English (en)

Norwegian (no)

Other versions

NO20032846D0 (no

Inventor

Sulejman Alihodzic

Alfonso Pozzan

Daniele Andreotti

Catia Seri

Luca Arista

Luca Tarsi

Stefano Biondi

Silvia Terreni

Francesca Cardullo

Jessica Tibasco

Manuela Ciraco

Frederica Damiani

Sergio Lociuro

Carla Marchioro

Giancarlo Merlo

Anna Mingardi

Daniela Niccolai

Alfredo Paio

Elisabetta Piga

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-21

Filing date

2003-06-20

Publication date

2003-08-20

2000-12-21 Priority claimed from GB0031309A external-priority patent/GB0031309D0/en

2001-11-01 Priority claimed from GB0126276A external-priority patent/GB0126276D0/en

2001-11-01 Priority claimed from GB0126277A external-priority patent/GB0126277D0/en

2003-06-20 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2003-06-20 Publication of NO20032846D0 publication Critical patent/NO20032846D0/no

2003-08-20 Publication of NO20032846L publication Critical patent/NO20032846L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Biophysics (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

NO20032846A 2000-12-21 2003-06-20 Makrolider NO20032846L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0031309A GB0031309D0 (en)	2000-12-21	2000-12-21	Macrolides
GB0126276A GB0126276D0 (en)	2001-11-01	2001-11-01	Macolides
GB0126277A GB0126277D0 (en)	2001-11-01	2001-11-01	Macrolides
PCT/GB2001/005665 WO2002050091A1 (fr)	2000-12-21	2001-12-20	Antibiotiques a base de macrolides

Publications (2)

Publication Number	Publication Date
NO20032846D0 NO20032846D0 (no)	2003-06-20
NO20032846L true NO20032846L (no)	2003-08-20

Family

ID=27256023

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20032846A NO20032846L (no)	2000-12-21	2003-06-20	Makrolider

Country Status (20)

Country	Link
US (3)	US20040077557A1 (fr)
EP (1)	EP1363925B8 (fr)
JP (1)	JP2004531471A (fr)
KR (1)	KR20030068189A (fr)
CN (1)	CN1492874A (fr)
AR (1)	AR042583A1 (fr)
AT (1)	ATE345350T1 (fr)
AU (2)	AU2002217277B2 (fr)
BR (1)	BR0116431A (fr)
CA (1)	CA2432429A1 (fr)
CZ (1)	CZ20031751A3 (fr)
DE (1)	DE60124594T2 (fr)
ES (1)	ES2275621T3 (fr)
HU (1)	HUP0302526A2 (fr)
IL (1)	IL156561A0 (fr)
MX (1)	MXPA03005668A (fr)
NO (1)	NO20032846L (fr)
NZ (1)	NZ526450A (fr)
PL (1)	PL365012A1 (fr)
WO (1)	WO2002050091A1 (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE538794T1 (de)	1999-01-13	2012-01-15	Bayer Healthcare Llc	Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
US8124630B2 (en)	1999-01-13	2012-02-28	Bayer Healthcare Llc	ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
MXPA04007832A (es)	2002-02-11	2005-09-08	Bayer Pharmaceuticals Corp	Aril-ureas con actividad inhibitoria de angiogenesis.
US6995143B2 (en) *	2002-02-28	2006-02-07	Basilea Pharmaceutica Ag	Macrolides with antibacterial activity
US6727229B2 (en)	2002-08-19	2004-04-27	Enanta Pharmaceuticals, Inc.	11,12-substituted lactone ketolide derivatives having antibacterial activity
US6720308B1 (en)	2002-11-07	2004-04-13	Enanta Pharmaceuticals, Inc.	Anhydrolide derivatives having antibacterial activity
HRP20020886A2 (en) *	2002-11-11	2005-06-30	PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o.	SUBSTITUTED 9a-N-[N'-(BENZENSULFONYL)CARBAMOYL-γ-AMINOPROPYL) AND 9a-N(N' -(?-CYANOETHIL)-N' -(b
HRP20020991A2 (en) *	2002-12-12	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
EP1636585B2 (fr)	2003-05-20	2012-06-13	Bayer HealthCare LLC	Diaryl-urees presentant une activite d'inhibition des kinases
US6716820B1 (en)	2003-06-05	2004-04-06	Enanta Pharmaceuticals, Inc.	6-O-substituted bicyclic macrolides
US6774115B1 (en)	2003-06-05	2004-08-10	Enanta Pharmaceuticals, Inc.	6-O-substituted bicyclic ketolides
US6790835B1 (en)	2003-06-05	2004-09-14	Enanta Pharmaceuticals, Inc.	Bicyclic macrolide derivatives
US6765016B1 (en)	2003-06-05	2004-07-20	Enanta Pharmaceuticals, Inc.	Bicyclic ketolide derivatives
HRP20060073B1 (hr)	2003-07-23	2014-03-14	Bayer Healthcare Llc	Fluoro supstituirana omega-karboksiaril difenil urea za lijeäśenje i prevenciju bolesti i stanja
CA2533824A1 (fr) *	2003-07-31	2005-02-10	Irm, Llc	Composes bicycliques et compositions utilisees comme inhibiteurs pdf
WO2005019212A1 (fr) *	2003-08-20	2005-03-03	Eli Lilly And Company	Composes, procedes et preparations destines a l'apport oral d'un compose peptidique de type glucagon (glp-1) ou d'un peptide agoniste du recepteur 4 de melanocortine (mc4)
ES2278346T3 (es)	2003-08-20	2007-08-01	Eli Lilly And Company	Compuestos, procedimientos y formulaciones para suministro oral de un compuesto peptido (glp)-1 del tipo de glucagon o un peptido agonista (glp)-4 del receptor 4 de melacortina (mc4).
RU2403237C2 (ru) *	2004-05-14	2010-11-10	Эмисфире Текнолоджис, Инк.	Составы и смеси для доставки активных агентов
CA2591746A1 (fr)	2004-12-21	2006-06-29	Pfizer Products Inc.	Macrolides
CN101115764B (zh) *	2005-02-09	2012-09-26	巴斯利尔药物股份公司	大环内酯类化合物
WO2006120541A1 (fr)	2005-05-10	2006-11-16	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Macrolides a liaison ether convenant pour le traitement des infections microbiennes
EP1994928A4 (fr) *	2006-03-10	2010-08-11	Yuuzou Tsuchida	Agent antimicrobien et composition antimicrobienne
RU2455308C2 (ru) *	2006-05-01	2012-07-10	Тайсо Фармасьютикал Ко., Лтд.	Макролидные производные
KR20090042971A (ko) *	2006-08-24	2009-05-04	욱크하르트 리서치 센터	항미생물 활성을 갖는 신규한 마크로라이드 및 케토라이드
CN101506203B (zh)	2006-08-24	2013-10-16	诺瓦提斯公司	治疗代谢病、心血管病和其他病症的作为硬脂酰辅酶a脱饱和酶(scd)抑制剂的2-(吡嗪-2-基)-噻唑和2-(1h-吡唑-3-基)-噻唑衍生物及相关化合物
JP5351025B2 (ja)	2006-09-22	2013-11-27	ノバルティスアーゲー	ヘテロ環式有機化合物
JP2010513403A (ja)	2006-12-20	2010-04-30	ノバルティスアーゲー	Ｓｃｄ阻害剤としての２−置換５員ヘテロ環
WO2010011302A1 (fr) *	2008-07-22	2010-01-28	Chdi, Inc.	Inhibiteurs de kynurénine-3-monooxygénase, compositions pharmaceutiques et leurs procédés d'utilisation
US20120041194A1 (en) *	2008-08-29	2012-02-16	Triad Multitech Pharmaceuticals, Inc.	Nitrogen and sulfur-containing hetrocycle derivatives
AU2010252641B2 (en)	2009-05-27	2015-09-17	Wockhardt Research Centre	Ketolide compounds having antimicrobial activity
WO2012008549A1 (fr)	2010-07-15	2012-01-19	武田薬品工業株式会社	Composé hétérocyclique
CN102417530A (zh) *	2010-09-26	2012-04-18	中国医学科学院药物研究所	广谱抗菌素红霉素a大环酮内酯类衍生物的合成方法和用途
MX348084B (es) *	2010-12-09	2017-05-26	Wockhardt Ltd	Compuestos de cetolido.
WO2012117357A2 (fr)	2011-03-01	2012-09-07	Wockhardt Limited	Procédé de préparation d'intermédiaires de cétolides
CA2844521A1 (fr)	2011-08-30	2013-03-07	Chdi Foundation, Inc.	Inhibiteurs de kynurenine-3-monooxygenase, compositions pharmaceutiques et procedes d'utilisation de ces compositions
DK2750677T3 (en)	2011-08-30	2017-07-10	Chdi Foundation Inc	KYNURENIN-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND PROCEDURES FOR USE THEREOF
US8940742B2 (en)	2012-04-10	2015-01-27	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
MX389256B (es)	2013-10-04	2025-03-20	Infinity Pharmaceuticals Inc	Compuestos heterociclicos y usos de los mismos.
US9751888B2 (en)	2013-10-04	2017-09-05	Infinity Pharmaceuticals, Inc.	Heterocyclic compounds and uses thereof
EA201691872A1 (ru)	2014-03-19	2017-04-28	Инфинити Фармасьютикалз, Инк.	Гетероциклические соединения для применения в лечении pi3k-гамма-опосредованных расстройств
CR20170061A (es)	2014-07-17	2017-07-17	Chdi Foundation Inc	Métodos y composiciones para el tratamiento de trastornos relacionados con vih
WO2016054491A1 (fr)	2014-10-03	2016-04-07	Infinity Pharmaceuticals, Inc.	Composés hétérocycliques et leurs utilisations
KR20160061743A (ko)	2014-11-24	2016-06-01	주식회사 엘지화학	고흡수성 수지 및 이의 제조 방법
CN108349985A (zh)	2015-09-14	2018-07-31	无限药品股份有限公司	异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法
WO2017161116A1 (fr)	2016-03-17	2017-09-21	Infinity Pharmaceuticals, Inc.	Isotopologues de composés isoquinolinone et quinazolinone et leurs utilisations comme inhibiteurs de la kinase pi3k
WO2017214269A1 (fr)	2016-06-08	2017-12-14	Infinity Pharmaceuticals, Inc.	Composés hétérocycliques et leurs utilisations
CN110272417B (zh) *	2019-06-18	2021-07-13	五邑大学	2-甲基-1,8-萘啶类化合物及其制备方法与应用
AU2020394867A1 (en)	2019-12-02	2022-05-26	Storm Therapeutics Limited	Polyheterocyclic compounds as METTL3 inhibitors
US11999703B1 (en)	2023-10-25	2024-06-04	King Faisal University	5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid as an antimicrobial compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2732684B1 (fr) *	1995-04-06	1997-04-30	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) *	1995-12-22	1998-01-30	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP2003527301A (ja) *	1997-10-29	2003-09-16	大正製薬株式会社	エリスロマイシンａ誘導体
WO1999021870A1 (fr) *	1997-10-29	1999-05-06	Taisho Pharmaceutical Co., Ltd.	Derives de l'erythromycine a 11,12-carbamate
OA11753A (en) *	1999-01-27	2005-07-19	Pfizer Prod Inc	Ketolide antibiotics.
US6355620B1 (en) *	1999-05-14	2002-03-12	Abbott Laboratories	C-2 modified erythromycin derivatives
EP1114826A3 (fr) *	1999-12-29	2001-10-31	Pfizer Products Inc.	Macrolides antibactériennes et prokinétiques
MXPA03001607A (es) *	2000-08-22	2003-06-04	Basilea Pharmaceutica Ag	Nuevos macrolidos con actividad antibacteriana.
JP2005503416A (ja) *	2001-09-17	2005-02-03	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	６−ｏ−カルバメート−１１，１２−ラクト−ケトライド抗菌剤

2001
- 2001-12-20 CZ CZ20031751A patent/CZ20031751A3/cs unknown
- 2001-12-20 AU AU2002217277A patent/AU2002217277B2/en not_active Expired - Fee Related
- 2001-12-20 MX MXPA03005668A patent/MXPA03005668A/es not_active Application Discontinuation
- 2001-12-20 WO PCT/GB2001/005665 patent/WO2002050091A1/fr not_active Ceased
- 2001-12-20 IL IL15656101A patent/IL156561A0/xx unknown
- 2001-12-20 CN CNA018226515A patent/CN1492874A/zh active Pending
- 2001-12-20 BR BR0116431-7A patent/BR0116431A/pt not_active IP Right Cessation
- 2001-12-20 PL PL01365012A patent/PL365012A1/xx not_active Application Discontinuation
- 2001-12-20 DE DE60124594T patent/DE60124594T2/de not_active Expired - Fee Related
- 2001-12-20 CA CA002432429A patent/CA2432429A1/fr not_active Abandoned
- 2001-12-20 NZ NZ526450A patent/NZ526450A/en unknown
- 2001-12-20 US US10/450,893 patent/US20040077557A1/en not_active Abandoned
- 2001-12-20 AU AU1727702A patent/AU1727702A/xx active Pending
- 2001-12-20 KR KR10-2003-7008377A patent/KR20030068189A/ko not_active Withdrawn
- 2001-12-20 HU HU0302526A patent/HUP0302526A2/hu unknown
- 2001-12-20 ES ES01271380T patent/ES2275621T3/es not_active Expired - Lifetime
- 2001-12-20 JP JP2002551984A patent/JP2004531471A/ja not_active Ceased
- 2001-12-20 EP EP01271380A patent/EP1363925B8/fr not_active Expired - Lifetime
- 2001-12-20 AT AT01271380T patent/ATE345350T1/de not_active IP Right Cessation
- 2001-12-21 AR ARP010105997A patent/AR042583A1/es unknown
2003
- 2003-06-20 NO NO20032846A patent/NO20032846L/no not_active Application Discontinuation
2005
- 2005-05-12 US US11/127,701 patent/US20050215495A1/en not_active Abandoned
2006
- 2006-06-05 US US11/422,122 patent/US20060211636A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1363925B8 (fr)	2007-04-25
AU1727702A (en)	2002-07-01
US20050215495A1 (en)	2005-09-29
PL365012A1 (en)	2004-12-27
US20040077557A1 (en)	2004-04-22
AR042583A1 (es)	2005-06-29
CN1492874A (zh)	2004-04-28
IL156561A0 (en)	2004-01-04
BR0116431A (pt)	2004-06-22
EP1363925A1 (fr)	2003-11-26
MXPA03005668A (es)	2004-12-03
HUP0302526A2 (hu)	2003-11-28
ES2275621T3 (es)	2007-06-16
AU2002217277B2 (en)	2005-06-16
CZ20031751A3 (cs)	2004-03-17
DE60124594T2 (de)	2007-10-04
DE60124594D1 (de)	2006-12-28
JP2004531471A (ja)	2004-10-14
CA2432429A1 (fr)	2002-06-27
NO20032846D0 (no)	2003-06-20
EP1363925B1 (fr)	2006-11-15
ATE345350T1 (de)	2006-12-15
NZ526450A (en)	2005-04-29
WO2002050091A1 (fr)	2002-06-27
US20060211636A1 (en)	2006-09-21
KR20030068189A (ko)	2003-08-19

Publication	Publication Date	Title
NO20032846D0 (no)	2003-06-20	Makrolider
ATE252099T1 (de)	2003-11-15	Biarylcarboxamide
DE10136334B8 (de)	2009-11-26	Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser
ATE312098T1 (de)	2005-12-15	Thiazinoxazolidinon
ATA2932001A (de)	2004-11-15	Schneefräse
DE50106867D1 (de)	2005-09-01	Kugelgelenk
DE50102988D1 (de)	2004-09-02	Bodenwischer
DE50104056D1 (de)	2004-11-18	Gewichtsmanschette
ATE262530T1 (de)	2004-04-15	Indolochinazolinone
PT1268453E (pt)	2006-10-31	Metabolitos de agonista/antagonista de estrogenio
DE10192638T1 (de)	2002-10-31	Bohrstangenladevorrichtung
AR028336A1 (es)	2003-05-07	4-hidroxi-tetrahidropiridonas fenilsubstituidas
ATE509008T1 (de)	2011-05-15	Sulfonylguanidine
DE10196064T1 (de)	2003-03-13	Halbleiterfotodektionsgerät
DE50100817D1 (de)	2003-11-27	Kugelgelenk
DE50011511D1 (de)	2005-12-08	Blowby-Heizung
AR027931A1 (es)	2003-04-16	Antitranspirantes
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
PT1317179E (pt)	2004-08-31	Formulacoes de mesotriona
DE10052925B4 (de)	2005-03-10	Schaukelbett
ATE476423T1 (de)	2010-08-15	Benzoylpyridazine
DE10195909T1 (de)	2003-02-20	Viehfüttervorrichtung
DE10085445T1 (de)	2003-02-27	Drahterodierbearbeitungseinrichtung
AR027982A1 (es)	2003-04-23	Aril- y heteroarilsulfonatos
NO20023353D0 (no)	2002-07-11	Geofonkobling

Legal Events

Date	Code	Title	Description
2006-07-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application